apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Pacshil 260Mg/43.4Ml Injection

  3. Pacshil 260Mg/43.4Ml Injection Substitute

Pacshil 260Mg/43.4Ml Injection Substitute

Medicine Composition:

PACLITAXEL-260MG

All Substitutes & Brand Comparisons

call Doctor

When Should You Consider Switching from Pacshil 260Mg/43.4Ml Injection?

Patients may explore substitutes in the following scenarios:

  • High monthly cost of Pacshil 260Mg/43.4Ml Injection
  • Non-availability in local pharmacies
  • Generic recommendation by a doctor
  • Side effects or better tolerability with alternatives

What to Know Before Switching

Before you switch from Pacshil 260Mg/43.4Ml Injection to another medicine, here are some important points to keep in mind:

bannner image

Same salt, different brands:

Most substitutes contain the same active ingredient - PACLITAXEL-260MG, but the fillers, coating, or manufacturing quality may vary slightly.

bannner image

Consult your doctor first:

Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.

bannner image

Watch out for allergies or reactions:

Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.

bannner image

Price ≠ effectiveness:

A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.

bannner image

Check the dosage form and strength:

Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.

Uses

Pacshil 260Mg/43.4Ml Injection is used in the treatment of ovarian cancer, breast cancer, and non-small cell lung cancer. The detailed uses of Pacshil 260Mg/43.4Ml Injection are as follows:

  • Treating Ovarian Cancer: Pacshil 260Mg/43.4Ml Injection helps to treat ovarian cancer by inhibiting cancer cell growth and proliferation.
  • Managing Breast Cancer: Pacshil 260Mg/43.4Ml Injection is used to manage breast cancer, particularly in patients with metastatic disease, slowing disease progression and improving symptoms.
  • Treating Non-Small Cell Lung Cancer (NSCLC): Pacshil 260Mg/43.4Ml Injection treats NSCLC by interfering with cell division, inhibiting tumour growth, and slowing disease progression.
  • Reducing Tumour Growth in AIDS-Related Kaposi Sarcoma: Pacshil 260Mg/43.4Ml Injection also helps to manage Kaposi sarcoma in patients with AIDS by reducing tumour growth and alleviating symptoms.

Medicinal Benefits

Pacshil 260Mg/43.4Ml Injection belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. It may also be used when other treatments have failed or in combination with other treatments. Pacshil 260Mg/43.4Ml Injection may also be indicated in patients with Kaposi’s sarcoma (cancer that develops from the cells that line lymph or blood vessels) associated with AIDS (Acquired Immuno-Deficiency Syndrome), where other treatments have not been effective. Pacshil 260Mg/43.4Ml Injection contains ‘Paclitaxel’, which works by preventing the growth of certain cancer cells. 

FAQs

The substitutes of Pacshil 260Mg/43.4Ml Injection contain the same active salt(s) - PACLITAXEL-260MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Pacshil 260Mg/43.4Ml Injection is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Pacshil 260Mg/43.4Ml Injection are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Pacshil 260Mg/43.4Ml Injection meet the same safety and efficacy standards as Pacshil 260Mg/43.4Ml Injection, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Pacshil 260Mg/43.4Ml Injection may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Pacshil 260Mg/43.4Ml Injection if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Pacshil 260Mg/43.4Ml Injection for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Pacshil 260Mg/43.4Ml Injection is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Pacshil 260Mg/43.4Ml Injection to its substitute. Always consult your doctor before switching.
Pacshil 260Mg/43.4Ml Injection is used to treat Ovarian cancer, breast cancer, non-small cell lung cancer.
Pacshil 260Mg/43.4Ml Injection works by stopping cell division and preventing the growth of certain cancer cells.
Pacshil 260Mg/43.4Ml Injection might cause sterility which could be permanent. Please talk to your doctor if you have any concerns.
The most common side effect of Pacshil 260Mg/43.4Ml Injection is hair loss. The hair may grow back after the treatment with Pacshil 260Mg/43.4Ml Injection is finished. However, consult your doctor if you have any concerns.
Yes, Pacshil 260Mg/43.4Ml Injection is cytotoxic. It works by interfering with the growth of cancer cells, preventing them from dividing and causing them to die. However, its cytotoxic nature also means it can affect normal, healthy cells, potentially leading to side effects.
Yes, Pacshil 260Mg/43.4Ml Injection is considered a vesicant. A vesicant is a chemical substance that, if it leaks out of the vein (extravasation), can cause blistering of the skin and surrounding tissues. If Pacshil 260Mg/43.4Ml Injection accidentally leaks during intravenous (IV) infusion, it may lead to inflammation, blistering, or even tissue necrosis. Your healthcare provider will take precautions to ensure the drug is infused properly and monitor the infusion site for any signs of leakage. If extravasation occurs, the infusion should be stopped immediately, and steps should be taken to minimize the damage.
Pacshil 260Mg/43.4Ml Injection is an effective cancer treatment with a low risk of cardiac side effects. Your healthcare team will closely monitor your heart function to ensure your safety. They'll watch for any changes in heart rhythms or blood pressure, and work with you to manage any potential issues. With careful monitoring, you can receive this life-saving treatment with confidence.
Pacshil 260Mg/43.4Ml Injection is a natural product derived from the bark of the Pacific yew tree (Taxus baccata). It is a chemotherapy medication used to treat various cancers, including breast, ovarian, and lung cancer.
The common side effects of Pacshil 260Mg/43.4Ml Injection include nausea, vomiting, mild diarrhoea, and joint or muscle pain. Not everyone will experience all of these side effects, and they typically resolve once the treatment is stopped. However, if the side effects persist or worsen, please consult your doctor.
Apollo 247 Floating Button

Buy best Neoplastic Disorders products by